Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22117196)

  • 1. Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo.
    Raimondi L; Ciarapica R; De Salvo M; Verginelli F; Gueguen M; Martini C; De Sio L; Cortese G; Locatelli M; Dang TP; Carlesso N; Miele L; Stifani S; Limon I; Locatelli F; Rota R
    Cell Death Differ; 2012 May; 19(5):871-81. PubMed ID: 22117196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.
    De Salvo M; Raimondi L; Vella S; Adesso L; Ciarapica R; Verginelli F; Pannuti A; Citti A; Boldrini R; Milano GM; Cacchione A; Ferrari A; Collini P; Rosolen A; Bisogno G; Alaggio R; Inserra A; Locatelli M; Stifani S; Screpanti I; Miele L; Locatelli F; Rota R
    PLoS One; 2014; 9(5):e96238. PubMed ID: 24797362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation.
    Casini N; Forte IM; Mastrogiovanni G; Pentimalli F; Angelucci A; Festuccia C; Tomei V; Ceccherini E; Di Marzo D; Schenone S; Botta M; Giordano A; Indovina P
    Oncotarget; 2015 May; 6(14):12421-35. PubMed ID: 25762618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoregulatory loop between TGF-β1/miR-411-5p/SPRY4 and MAPK pathway in rhabdomyosarcoma modulates proliferation and differentiation.
    Sun M; Huang F; Yu D; Zhang Y; Xu H; Zhang L; Li L; Dong L; Guo L; Wang S
    Cell Death Dis; 2015 Aug; 6(8):e1859. PubMed ID: 26291313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis.
    Belyea BC; Naini S; Bentley RC; Linardic CM
    Clin Cancer Res; 2011 Dec; 17(23):7324-36. PubMed ID: 21948088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.
    Hanna JA; Garcia MR; Go JC; Finkelstein D; Kodali K; Pagala V; Wang X; Peng J; Hatley ME
    Cell Death Dis; 2016 Jun; 7(6):e2256. PubMed ID: 27277678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RBPJ is a novel target for rhabdomyosarcoma therapy.
    Nagao H; Setoguchi T; Kitamoto S; Ishidou Y; Nagano S; Yokouchi M; Abematsu M; Kawabata N; Maeda S; Yonezawa S; Komiya S
    PLoS One; 2012; 7(7):e39268. PubMed ID: 22792167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma.
    Diao Y; Guo X; Jiang L; Wang G; Zhang C; Wan J; Jin Y; Wu Z
    J Biol Chem; 2014 Jan; 289(1):529-39. PubMed ID: 24247238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells.
    Zhu B; Zhang M; Byrum SD; Tackett AJ; Davie JK
    Int J Cancer; 2014 Aug; 135(4):785-97. PubMed ID: 24470334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of human rhabdomyosarcoma RD cells is regulated by reciprocal, functional interactions between myostatin, p38 and extracellular regulated kinase signalling pathways.
    Rossi S; Stoppani E; Puri PL; Fanzani A
    Eur J Cancer; 2011 May; 47(7):1095-105. PubMed ID: 21273059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.
    Masiero M; Minuzzo S; Pusceddu I; Moserle L; Persano L; Agnusdei V; Tosello V; Basso G; Amadori A; Indraccolo S
    Leukemia; 2011 Apr; 25(4):588-98. PubMed ID: 21263446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
    Skrzypek K; Kusienicka A; Szewczyk B; Adamus T; Lukasiewicz E; Miekus K; Majka M
    Oncotarget; 2015 Oct; 6(31):31378-98. PubMed ID: 26384300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
    Liu LN; Dias P; Houghton PJ
    Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.
    Megiorni F; Camero S; Ceccarelli S; McDowell HP; Mannarino O; Marampon F; Pizer B; Shukla R; Pizzuti A; Marchese C; Clerico A; Dominici C
    Oncotarget; 2016 Nov; 7(48):79342-79356. PubMed ID: 27764816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma.
    Giovannini C; Minguzzi M; Baglioni M; Fornari F; Giannone F; Ravaioli M; Cescon M; Chieco P; Bolondi L; Gramantieri L
    Oncotarget; 2014 Nov; 5(21):10607-20. PubMed ID: 25431954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
    Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
    Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta (TGF- 1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression.
    Kennard S; Liu H; Lilly B
    J Biol Chem; 2008 Jan; 283(3):1324-1333. PubMed ID: 17981798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells.
    Zhang M; Truscott J; Davie J
    Mol Cancer; 2013 Nov; 12(1):150. PubMed ID: 24279793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel small molecule DMAMCL induces differentiation in rhabdomyosarcoma by downregulating of DLL1.
    Li Q; Chen Y; Chen Y; Hua Z; Gong B; Liu Z; Thiele CJ; Li Z
    Biomed Pharmacother; 2024 May; 174():116562. PubMed ID: 38626518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.